|
[1]SCHUHMANN-GIAMPIERI G, SCHMITT-WILLICH H, PRESS WR, et al.Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system[J].Radiology, 1992, 183 (1) :59-64.
|
|
[2]LINAG L, CHEN CZ, RAO SX, et al.Study of clinical application of hepatic-biliary specific MR contrast agent (Gd-EOB-DTPA) in the diagnosis of focal lesions[J].Radiol Practice, 2012, 27 (7) :765-770. (in Chinese) 梁亮, 陈财忠, 饶圣祥, 等.肝胆特异性磁共振对比剂GdEOB-DTPA在肝脏局灶性病变诊断中的应用研究[J].放射学实践, 2012, 27 (7) :765-770.
|
|
[3]SEUNG HK, WOO KJ, YONGSOO K, et al.Hepatocellular carcinoma composed of two different histologic types:imaging features on gadoxetic acid-enhanced liver MRI[J].Clin Mol Hepatol, 2013, 19 (1) :92-96.
|
|
[4]CHOL JW, LEE JM, KIM SJ, et al.Hepatocellular carcinoma:imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker[J].Radiology, 2013, 267 (3) :776-786.
|
|
[5]RAMAN SS, LEARY C, BLUEMKE DA, et al.Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging:a multicenter phase 3 clinical trial[J].J Comput Assist Tomogr, 2010, 34 (2) :163-172.
|
|
[6]ICHIKAWA T, SATIO K, YOSHIOKA N, et al.Detection and characterization of focal liver lesions:a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease[J].Invest Radiol, 2010, 45 (3) :133-141.
|
|
[7]SUN HY, LEE JM, SHIN CI, et al.Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (<2 cm in diameter) from arterial enhancing pseudolesions[J].Invest Radiol, 2010, 45 (2) :96-103.
|
|
[8]KIM HY, CHOI JY, KIM CW, et al.Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis[J].Liver Transpl, 2012, 18 (7) :850-857.
|
|
[9]Marin D, Brancatelli G, Federle MP, et al.Focal nodular hyperplasia:typical and atypical MRI findings with emphasis on the use of contrast media[J].Clin Radiol, 2008, 63 (5) :577-585.
|
|
[10]KITAO A, MATSUI O, YONEDA N, et al.The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis:correlation with gadoxetic acid enhanced MR imaging[J].Eur Radiol, 2011, 21 (10) :2056-2066.
|
|
[11]KANKI A, TAMADA T, HIGAKI A, et al.Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging:correlation with morphological grading of severity in cirrhosis and chronic hepatitis[J].Magn Reson Imaging, 2012, 30 (3) :356-360.
|
|
[12]International Working Party.Terminology of nodular hepatocellular lesions[J].Hepatology, 1995, 22 (3) :983-993.
|
|
[13]TAMADA T, ITO K, UEKI A, et al.Peripheral low intensity sign in hepatic hemangioma:diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver[J].J Magn Reson Imaging, 2012, 35 (4) :852-858.
|
DownLoad: